Biogen Inc. is a biopharmaceutical firm dedicated to the discovery, advancement, and provision of treatments for conditions affecting the nervous system. Headquartered in Cambridge, Massachusetts, the company employs 7,800 full-time staff. Its primary focus involves the research, development, production, and distribution of therapies targeting a range of severe neurological, rare, and autoimmune disorders.